You Can Do Better Than Rocket Labs With This 1 ETF

The Defiance Drone and Modern Warfare ETF (JEDI), launched September 2025, holds 26 companies deriving at least 50% of revenue from military drones, AI-driven warfare, defense tech and space, with a 10% cap per stock and the top 10 comprising 64% of assets; Rocket Lab is the largest holding at 8.66%. Recent one-year gains among top names are pronounced (Saab +282%, Kratos +242.4%, Rocket Lab +180.8%), and Rocket Lab’s strong government business includes $816m and $515m contracts and 21 successful 2025 launches. Thematic tailwinds include proposed U.S. defense budget expansion and accelerating military space/cyber demand; the fund’s 0.69% expense ratio is noted as a tradeoff for diversified exposure.

Analysis

Market structure: Fiscal tailwinds (article cites a push toward $1.5T defense spending in 2027) re-price a clustered set of beneficiaries: RKLB, KTOS, PLTR, RTX, LHX, ESLT and AVAV should see revenue visibility and backlog expansion over 12–36 months, while civilian-capex and long-duration growth names are susceptible to multiple contraction if bond yields rise. JEDI’s top-10 = 64% weight concentration creates de facto active exposure to mid/small defense primes despite a 0.69% fee; this caps single-name beta but amplifies thematic correlation risk across launch suppliers, missile-tracking and AI analytics vendors.

Risk assessment: Tail risks include a rapid geopolitical de-escalation (Ukraine peace or U.S. budget rollback) that could remove >20–30% of incremental revenue assumptions for many names within 12 months, export-control shocks to PLTR/ESLT, and operational failure (RKLB launch loss) that can erase >30% equity value short-term. Near-term (days–weeks) volatility will track contract announcements and launch cadence; medium-term (3–12 months) depends on DoD budget passage and major RFP outcomes; long-term (2–5 years) depends on sustained procurement cycles and supply-chain scaling for composites/semiconductors.

Trade implications: Favor concentrated equity exposure to high-growth mids (RKLB, KTOS) rather than the ETF as a tactical play sized 2–5% per name with stop-losses; use JEDI (ticker JEDI) as a 1–2% thematic satellite for diversified exposure, given fee drag. Options: buy 9–12 month call spreads on RKLB and KTOS to cap premium (target +40% upside, max loss ~10% of position). Consider pair trades long KTOS vs short LDOS to express drone/sensor upside vs commoditized systems-integration risks over 6–12 months.

Contrarian angles: The consensus ignores revenue-quality dispersion — many names are dual-use with commercial cyclicality; small-cap drone names (AVAV, KTOS) may be overbought into headlines and vulnerable to mean reversion of 20–40% absent contracted backlog. Historical parallel: post-2014 defense spikes faded as budgets normalized; if election or budget politics flip by 2027, expect 30–50% downside scenarios for the most leveraged thematic plays. Also expect increased ESG/expo restrictions and export-controls as an unintended consequence that can re-rate European vs U.S. suppliers differently.

Key Decisions for Investors

• Establish a 3% long position in Rocket Lab (RKLB) sized as 3% of portfolio cash: target +40% in 9–12 months, trim 50% of the position if price rises +30%, stop-loss at -25% from entry; use a 12-month 30% OTM call spread if you prefer defined risk.
• Build a 2–3% long position in Kratos (KTOS) and simultaneously short 2% Leidos (LDOS) as a pair trade (long KTOS / short LDOS) to express high-performance drone/satcom upside vs legacy systems integration; target spread widening 30% in 6–12 months, close if KTOS falls 30% or LDOS outperforms by 20%.
• Allocate 1.5% to the Defiance Drone & Modern Warfare ETF (JEDI) as a diversified satellite holding for multi-name exposure while avoiding single-name execution risk; rebalance quarterly and limit total ETF exposure to 5% of portfolio due to 0.69% expense drag.
• Buy 9–12 month call spreads on KTOS and RKLB (size equal to ~1% equity each) rather than outright longs to capture event-driven upside (contract awards, launch cadence). Set max premium at ~10% of the equity-sized position and exit if implied volatility rises >50% vs entry or after major contract award is announced.
• Monitor three discrete catalysts in the next 30–180 days: (1) DoD FY2027 appropriation language (watch for +/−$200B shifts) by Sep 2026, (2) Golden Dome RFP calendar and SDA awards in next 6 months, and (3) RKLB launch success rate (next 2–3 launches). If any catalyst signals funding >$200B incremental or multiple major awards to a name, scale positions up to +50%; if funding is cut or launch failures occur, reduce positions by 50% immediately.